COMP <GO>
LIVN vs AXGN // 10Y YIELD & FRED MACRO BETA
LivaNova PLC (NASDAQ) VS. Axogen Inc. (NASDAQ) • 15-METRIC TALLY: LIVN 5
— AXGN 5
■ METRIC PARITY
LAST: $78.97 (-2.81%) • MKT CAP: $4.48B
macro-sensitivity
—
LAST: $49.37 (-0.52%) • MKT CAP: $2.96B
macro-sensitivity
1.10
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LIVN VS. AXGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LIVN | AXGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.70% | 74.30% | -6.60 | AXGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.30% | -2.60% | +19.90 | LIVN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.6x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.87% | -0.10% | +3.97 | LIVN | /fcf-yield <GO> |
| Operating Margin | 14.40% | -3.50% | +17.90 | LIVN | /operating-margins <GO> |
| Net Profit Margin | -17.50% | -7.00% | -10.50 | AXGN | /net-margins <GO> |
| Revenue Growth (YoY) | 10.70% | 20.20% | -9.50 | AXGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.21 | 18.64 | -16.43 | AXGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | LIVN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.2 | 74.3 | -16.10 | AXGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 1.10 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.48B | $2.96B | $1.51B | LIVN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LIVN REV | AXGN REV | LIVN GROSS % | AXGN GROSS % | LIVN FCF | AXGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.39B | $225.2M | 67.7% | 74.3% | $173.3M | -$2.9M |
| FY 2024 | $1.25B | $187.3M | 68.1% | 75.8% | $135.9M | $1.4M |
| FY 2023 | $1.15B | $159.0M | — | — | $74.9M | -$12.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LIVN // BETA —
AXGN // BETA 1.10